Atlas Venture - We build breakthrough biotechnology companies.

Creating and building breakthrough biotechs for over 30 years

Partnering with the world's best life science entrepreneurs

Translating groundbreaking science into life-changing medicines

Scroll to explore

Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing

Diagonal Therapeutics Raises $128 Million to Discover Agonist Antibodies

Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program

Thirty years at the leading-edge of medical innovation and we’re just getting started.